ATE90876T1 - -i(d)-gl-konjugattherapie. - Google Patents
-i(d)-gl-konjugattherapie.Info
- Publication number
- ATE90876T1 ATE90876T1 AT87901796T AT87901796T ATE90876T1 AT E90876 T1 ATE90876 T1 AT E90876T1 AT 87901796 T AT87901796 T AT 87901796T AT 87901796 T AT87901796 T AT 87901796T AT E90876 T1 ATE90876 T1 AT E90876T1
- Authority
- AT
- Austria
- Prior art keywords
- conjugate therapy
- conjugate
- therapy
- lysine
- antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyamides (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86939386A | 1986-05-30 | 1986-05-30 | |
| PCT/US1987/000197 WO1987007145A1 (en) | 1986-05-30 | 1987-02-02 | D-gl conjugate therapy |
| EP87901796A EP0272278B1 (de) | 1986-05-30 | 1987-02-02 | $i(D)-GL-KONJUGATTHERAPIE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE90876T1 true ATE90876T1 (de) | 1993-07-15 |
Family
ID=25353468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87901796T ATE90876T1 (de) | 1986-05-30 | 1987-02-02 | -i(d)-gl-konjugattherapie. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0272278B1 (de) |
| JP (1) | JPS63503457A (de) |
| AT (1) | ATE90876T1 (de) |
| CA (1) | CA1309558C (de) |
| DE (1) | DE3786334T2 (de) |
| DK (1) | DK33488D0 (de) |
| NO (1) | NO880376L (de) |
| WO (1) | WO1987007145A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6441025B2 (en) * | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191668A (en) * | 1977-02-03 | 1980-03-04 | Scripps Clinic And Research Foundation | Induction of immunological tolerance |
-
1986
- 1986-10-10 CA CA000520250A patent/CA1309558C/en not_active Expired - Lifetime
-
1987
- 1987-02-02 JP JP62501436A patent/JPS63503457A/ja active Pending
- 1987-02-02 DE DE87901796T patent/DE3786334T2/de not_active Expired - Fee Related
- 1987-02-02 EP EP87901796A patent/EP0272278B1/de not_active Expired - Lifetime
- 1987-02-02 WO PCT/US1987/000197 patent/WO1987007145A1/en active IP Right Grant
- 1987-02-02 AT AT87901796T patent/ATE90876T1/de active
-
1988
- 1988-01-25 DK DK033488A patent/DK33488D0/da not_active Application Discontinuation
- 1988-01-28 NO NO880376A patent/NO880376L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1309558C (en) | 1992-10-27 |
| DK33488A (da) | 1988-01-25 |
| EP0272278B1 (de) | 1993-06-23 |
| WO1987007145A1 (en) | 1987-12-03 |
| DE3786334T2 (de) | 1993-12-02 |
| NO880376D0 (no) | 1988-01-28 |
| EP0272278A4 (de) | 1990-01-08 |
| NO880376L (no) | 1988-01-28 |
| DK33488D0 (da) | 1988-01-25 |
| JPS63503457A (ja) | 1988-12-15 |
| AU604687B2 (en) | 1991-01-03 |
| EP0272278A1 (de) | 1988-06-29 |
| AU7082987A (en) | 1987-12-22 |
| DE3786334D1 (de) | 1993-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1137436T3 (da) | Stimulering af T-celler mod selvantigener under anvendelse af CTLA-4-blokeringsmidler | |
| RU98100114A (ru) | Использование нейро-производных эмбриональных клеточных линий для трансплантационной терапии | |
| BR9909011A (pt) | Análogo de antìgeno covalentemente reativo (craa), processos para tratar um estado de doença em um paciente inibindo-se irreversivelmente a ação de um anticorpo catalìtico, e para estimular a produção de anticorpos com atividade catalìtica, anticorpo catalìtico, processos para tratar um estado de doença em um paciente, para inibir o anticorpo catalìtico, e para imunizar passivamente um paciente, e, preparação farmacêutica para tratar uma condição patológica relacionada com a presença de anticorpos catalìticos endogenamente produzidos | |
| DK442788A (da) | Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser | |
| PT627933E (pt) | Supressao "bystander" de doencas autoimunes | |
| PT743856E (pt) | Heteropolimeros a base de antigenes e metodo para o tratamento de doencas auto-imunes utilizando esses heteropolimeros | |
| NO885199D0 (no) | Fremgangsmte for fremstilling av monoklonale antistoffkonjugater. | |
| DK0651646T3 (da) | Terapeutiske konjugater af toksiner og lægemidler | |
| KR930702026A (ko) | 자기항원의 경구 투여에 의한 자기면역 질병의 치료 | |
| DK1593393T3 (da) | Anti-TNF-antistoffer og methotrexat i den ledsagende behandling af autoimmune sygdomme | |
| DE59611341D1 (de) | Verwendung von saccharid-konjugaten | |
| UY25262A1 (es) | 5-derivados sustituidos del ácido micofenolico | |
| YU75093A (sh) | Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka | |
| HUP9902429A2 (hu) | TNF-receptor-asszociált faktor (TRAF) modulátorok előállítása és alkalmazása | |
| ES2073425T3 (es) | Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina. | |
| DE69522689D1 (de) | Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper | |
| ATE90876T1 (de) | -i(d)-gl-konjugattherapie. | |
| FI973023A (fi) | Liikakasvusairauksien yhdistetty terapeuttinen hoito | |
| NO873512L (no) | Human lav-affinitets fcepsilon-reseptor, isolering, rekombinant fremstilling og rensing av denne. | |
| DE69724328D1 (de) | Konjugate von einem Interleukin-2 Rezeptor spezifisch erkennenden Faktor mit Ribonuklease | |
| Burnyasheva et al. | On the question of the treatment of urticaria | |
| Naor et al. | Induction of hapten recognizing helper function by heavily trinitrophenylated sheep erythrocytes | |
| RU94032140A (ru) | Способ лечения афазии | |
| RU97117537A (ru) | Мазь "черная" для лечения арахнозов, дерматомикозов и заболеваний кожи | |
| DK72088D0 (da) | Oximethere af 2,6-dioxabicyclo(3.3.0)octanoner og farmaceutiske praeparater til behandling af hjerte- og blodkredsloebssygdomme |